SCHEMBL4449531

SCHEMBL4449531

O=C(NC1CCN(Cc2ccccc2)CC1)c1cc2cc(OC3CCN(c4ccc(O)cc4)CC3)ccc2o1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.58
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
HPGD P15428 1/20 0.53
HSD17B10 Q99714 1/20 0.53
MAOB P27338 1/20 0.52
KCNH2 Q12809 1/20 0.49
MCHR1 Q99705 1/20 0.49
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
ME3 Q16798 1/20 0.48
DRD4 P21917 1/20 0.47
SLC6A12 P48065 1/20 0.47
SLC6A13 Q9NSD5 1/20 0.47
SIGMAR1 Q99720 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4452634 0.92 ACHE (0.48) ACHEKDM4EALDH1A1HPGDHSD17B10
SCHEMBL649755 0.91 SLC6A5 (0.54) ACHEKDM4EALDH1A1HPGDHSD17B10
SCHEMBL648725 0.91 CHRM4 (0.60) ACHEKDM4EALDH1A1HPGDHSD17B10
SCHEMBL4405711 0.91 ACHE (0.52) ACHEKDM4EALDH1A1HPGDHSD17B10
SCHEMBL649894 0.91 PRKAA2 (0.54) ACHEKDM4EALDH1A1HPGDHSD17B10
Trifluoroacetic Acid SCHEMBL650115 0.89 CHRM4 (0.58) ACHEKDM4EALDH1A1HPGDHSD17B10
Formic Acid SCHEMBL649213 0.88 PRKAA2 (0.51) ACHEKDM4EALDH1A1HPGDHSD17B10
SCHEMBL647657 0.88 ACHE (0.59) ACHEKDM4EALDH1A1HPGDHSD17B10
SCHEMBL4449419 0.86 MCHR1 (0.53) ACHEKCNH2MCHR1
SCHEMBL648322 0.86 DRD4 (0.52) ACHEKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115838-A1 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same RIGEL PHARMACEUTICALS, INC. (US) 2012-05-10 US disclosed
US-20110245222-A1 Methods for Using Carboxamide, Sulfonamide and Amine Compounds RIGEL PHARMACEUTICALS, INC. (US) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245222-A1 Methods for Using Carboxamide, Sulfonamide and Amine Compounds CS, SHMT2, GOT2 ACHE 2082/4885KDM4E 1431/4885ALDH1A1 804/4885
US-20120115838-A1 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same PRKAA1, PRKAA2, PRKAG1 ACHE 1963/4885KDM4E 714/4885ALDH1A1 1121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.